sinc
decemb
outbreak
coronaviru
diseas
caus
novel
coronaviru
emerg
hebei
provinc
china
spread
part
world
number
case
increas
rapidli
casefat
rate
detect
patient
specimen
first
crucial
step
guidanc
treatment
effect
infect
control
hospit
control
infect
commun
screen
infect
suspect
case
nucleic
acid
amplif
test
naat
realtim
polymeras
chain
reaction
rtpcr
respiratori
specimen
recommend
world
health
organ
howev
collect
nasopharyng
andor
oropharyng
swab
specimen
rel
invas
method
procedur
might
put
healthcar
worker
higher
risk
diseas
transmiss
patient
gag
reflex
cough
sneez
viral
load
demonstr
present
near
present
onset
use
saliva
sampl
specimen
screen
diseas
appeal
determin
potenti
use
saliva
sampl
diagnosi
conduct
prospect
studi
investig
correl
detect
saliva
sampl
nasopharyng
throat
swab
patient
investig
acut
respiratori
infect
clinic
univers
hospit
bangkok
thailand
detect
specimen
perform
realtim
rtpcr
amplif
n
gene
fragment
use
nucleic
acid
diagnost
kit
sansur
biotech
approv
detect
nation
medic
product
administr
nmpa
certifi
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
present
tabl
preval
diagnos
nasopharyng
throat
swab
rtpcr
saliva
rtpcr
studi
respect
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
previou
experiment
studi
show
higher
level
express
minor
salivari
gland
compar
lung
epitheli
cell
line
salivari
gland
also
detect
saliva
sampl
suggest
salivari
gland
could
potenti
target
infect
henc
saliva
could
potenti
sampl
detect
recent
find
detect
posterior
oropharyng
saliva
sampl
notabl
high
viral
load
diseas
present
protocol
earli
morn
saliva
collect
cough
clear
throat
studi
saliva
sampl
patient
selfgener
without
need
cough
invas
procedur
might
less
aerosolgener
might
reduc
risk
infect
health
care
worker
work
clinic
although
test
saliva
might
provid
advantag
easi
procedur
comparison
studi
saliva
confirm
case
bronchoalveolar
lavag
bal
fluid
convalesc
serum
titr
avail
recent
studi
detect
viru
multipl
site
show
lower
test
posit
rate
nasal
swab
compar
bronchoalveolar
lavag
fluid
therefor
fals
neg
test
saliva
sampl
might
possibl
would
area
explor
howev
spectrum
diseas
rang
asymptomat
upper
respiratori
tract
symptom
pneumonia
acut
respiratori
distress
syndrom
henc
discrep
detect
differ
specimen
might
also
possibl
studi
sever
strength
prospect
collect
data
consecut
patient
high
risk
infect
includ
acut
respiratori
symptom
risk
factor
thu
minim
potenti
spectrum
effect
enrol
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
